Will this expand the availability of credit to marginal companies or individuals? What are the implications for customer-supplier networks, the boundaries of the agency, or company governance? Will these developments lead to measurable enhancements in productivity? Regardless of the future path of the present pandemic, we predict that these points will not be simply forgotten and that analysis on these matters will proceed to evolve to incorporate extra information from epidemiology into economics and finance. After all, future pandemics might be around the nook, and this knowledge shall be necessary to prepare for them and guide future policies.